Stryker Improves Surgical Imaging with Novadaq Acquisition
On Monday Stryker Corp. announced its intent to acquire Canada-based Novadaq Technologies, Inc. for $701 million. The definitive agreement beefs up Stryker’s product portfolio in open and plastic reconstructive surgery, and is expected to provide surgeons with improved cross-specialty surgical visualization.
Novadaq develops fluorescence imaging technology, most notably the SPY Elite, for surgeons to enable visualization of blood flow in vessels, along with tissue perfusion in cardiac, cardiovascular, gastrointestinal, microsurgical, plastic and reconstructive surgery.
The transaction, which is structured under the Canada Business Corporations act and subject to closing conditions, is expected to close at the end of Q3 2017. The net purchase price of Novadaq will be $654 million.
Related Articles
-
“We are excited to combine Bomi’s talent, expertise and capabilities with UPS Healthcare—together, we will provide unmatched solutions to our customers, powered by UPS’s integrated, global smart logistics network.”
-
CVS Health has entered into a definitive agreement to acquire Signify Health, which boasts a network of more than 10,000 physicians, nurse practitioners and physician assistants that provide home-based visits.
-
Manufacturers preparing premarket submissions should provide performance specifications for the quantitative imaging functions, supporting performance data, and sufficient information for the end user to obtain, understand and interpret the values provided.
-
AI can support device innovation and surgical training, but it requires data and collaboration.
